AstraZeneca PLC — Director's Dealing 2013

Jun 12, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9037G

AstraZeneca PLC

12 June 2013

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 11 June 2013, Briggs Morrison, EVP, Global Medicines Development & Chief Medical Officer, a person discharging managerial responsibilities, was granted awards under the terms of the AstraZeneca Investment Plan (AZIP) and the AstraZeneca Performance Share Plan (AZPSP) over the Company's American Depositary Shares (ADSs) as detailed below.  One ADS equals one ordinary share.  A summary of these plans can be found in the AstraZeneca Annual Report and Form 20-F Information 2012 which is available on the Company's website www.astrazeneca.com.

Name	Shares awarded under AZIP	Shares awarded under AZPSP	Award price per share
Briggs Morrison	6,472	38,833	$51.45

The AZIP award is subject to a four-year performance period (1 January 2013 to 31 December 2016) and a subsequent four-year holding period (1 January 2017 to 31 December 2020).

The AZPSP award is subject to a three-year performance period (1 January 2013 to 31 December 2015).

More information about the performance measures that relate to these AZIP and AZPSP awards is set out in the Remuneration Committee Chairman's Speech and Presentation which was presented to shareholders at the Company's 2013 AGM, and which can be found at www.astrazeneca.com/Investors/Shareholder-information/Annual-General-Meeting.

A C N Kemp

Company Secretary

12 June 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUUAOROKANAAR